| Literature DB >> 24376800 |
Erin J Gilchrist1, Christine H D Sidebottom2, Chu Shin Koh2, Tanya Macinnes1, Andrew G Sharpe2, George W Haughn1.
Abstract
We have generated a Brassica napus (canola) population of 3,158 EMS-mutagenised lines and used TILLING to demonstrate that the population has a high enough mutation density that it will be useful for identification of mutations in genes of interest in this important crop species. TILLING is a reverse genetics technique that has been successfully used in many plant and animal species. Classical TILLING involves the generation of a mutagenised population, followed by screening of DNA samples using a mismatch-specific endonuclease that cleaves only those PCR products that carry a mutation. Polyacrylamide gel detection is then used to visualise the mutations in any gene of interest. We have used this TILLING technique to identify 432 unique mutations in 26 different genes in B. napus (canola cv. DH12075). This reflects a mutation density ranging from 1/56 kb to 1/308 kb (depending on the locus) with an average of 1/109 kb. We have also successfully verified the utility of next generation sequencing technology as a powerful approach for the identification of rare mutations in a population of plants, even in polyploid species such as B. napus. Most of the mutants we have identified are publically available.Entities:
Mesh:
Substances:
Year: 2013 PMID: 24376800 PMCID: PMC3869819 DOI: 10.1371/journal.pone.0084303
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Summary of B. napus EMS-mutagenised populations grown for TILLING.
|
|
|
|
|
|---|---|---|---|
| 0.10% | 90 | 36% | 4.4% |
| 0.10% | 185 | 26% | 3.2% |
| 0.15% | 108 | 38% | 7.4% |
| 0.15% | 254 | 21% | 3.9% |
| 0.20% | 156 | 19% | 7.0% |
| 0.20% | 187 | 52% | 12.8% |
| 0.20% | 222 | 9% | 3.6% |
| 0.20% | 727 | 72% | not screened |
| 0.25% | 188 | 16% | 9.6% |
| 0.25% | 874 | 64% | 23.6% |
| 0.25% | 972 | 87% | 15.2% |
| 0.30% | 162 | 10% | 1.9% |
| 0.30% | 504 | 46% | 7.7% |
| 0.30% | 828 | 49% | not screened |
| 0.40% | 216 | 5% | 1.0% |
| 0.40% | 558 | 50% | not screened |
| 0.40% | 654 | 34% | not screened |
| 0.45% | 688 | 58% | not screened |
Number of mutations identified and number of lines screened for each locus.
|
|
|
|
|
|
|
|---|---|---|---|---|---|
| bn1 | Stearoyl-acyl carrier protein desaturase | 21 | 1152 | 1505 | 1/72 |
| bn2 | Acyl-ACP thioesterase A | 8 | 1152 | 1534 | 1/192 |
| bn3 | β-ketoacyl-ACP synthetase II | 28 | 1920 | 1579 | 1/95 |
| bn4 | Lycopene epsilon cyclase | 22 | 1536 | 1813 | 1/112 |
| bn5 | Acyl-ACP thioesterase B | 20 | 1152 | 1655 | 1/84 |
| bn6 | Dihydroflavonol reductase | 13 | 1536 | 1596 | 1/165 |
| bn7 |
| 21 | 1152 | 1748 | 1/85 |
| bn9 | Phosphatidylinositol-dependent phospholipase 2 | 26 | 1536 | 1377 | 1/70 |
| bn13 | Lysophosphatidylcholine acyltransferase | 11 | 1152 | 1689 | 1/156 |
| bn14 | Lysophosphatidylcholine acyltransferase | 21 | 1536 | 2100 | 1/139 |
| bn15 |
| 17 | 1920 | 1605 | 1/159 |
| bn17 | Myo-inositol phosphate synthase | 38 | 1536 | 1583 | 1/56 |
| bn19 |
| 12 | 1152 | 1695 | 1/143 |
| bn20 |
| 9 | 1152 | 1702 | 1/192 |
| bn21 | Diglyceride acyltransferase 1 | 10 | 1536 | 1181 | 1/150 |
| bn22 | Diglyceride acyltransferase 1 | 2 | 384 | 1805 | 1/308 |
| bn23 | Diglyceride acyltransferase 1 | 29 | 1536 | 1798 | 1/85 |
| bn25 |
| 10 | 1152 | 1306 | 1/127 |
| bn26 |
| 12 | 1152 | 1739 | 1/148 |
| bn27 |
| 7 | 1152 | 1761 | 1/257 |
| bn29 | Acyl-ACP thioesterase A | 17 | 1152 | 1487 | 1/87 |
| bn30 | Acyl-ACP thioesterase B | 14 | 1152 | 1392 | 1/98 |
| bn31 | β-ketoacyl-ACP synthetase II | 17 | 768 | 1457 | 1/57 |
| bn36 |
| 15 | 1536 | 1781 | 1/162 |
| bn37 |
| 12 | 768 | 1782 | 1/101 |
| bn39 |
| 20 | 1536 | 1391 | 1/91 |
|
|
|
|
|
|
* Total number of mutations divided by the total number of kb of DNA screened. The amplicon size used for this calculation was reduced by 200bp as the ends of the amplicons cannot be screened using the LI-COR detection system
Number of mutations per plant in regions screened.
|
|
|
|---|---|
| 1,467 | 0 |
| 279 | 1 |
| 58 | 2 |
| 5 | 3 |
| 1 | 4 |
Predicted effect of mutations on gene product.
|
|
|
|
|---|---|---|
| nonsense | 18 | 4.2% |
| missense | 181 | 41.9% |
| silent | 233 | 53.9% |
Figure 1Sequencing read depth and mutation frequencies identified in 384 lines of the B. napus population.
The top panel represents the coverage of Illumina read depth (vertical axis) across the four amplicons developed for the target gene (bn1); a total of 1,530 bp (horizontal axis). The second, third and bottom panels represent the frequency (vertical axis) of candidate mutations (C to T, G to A, and A to G, respectively) identified in three pools (circled in red) of the 12 pools used in the analysis across the length of the target region in base pairs (horizontal axis). No A to G mutations were identified in the target locus and this is consistent with the mechanism of mutation induction by EMS.
Mutations identified by trial NGS sequencing (SCAMPRing) approach in 384 lines of the B. napus population.
|
|
|
|
|
|
|
|---|---|---|---|---|---|
| 475 | C>T | 2, 7, 12 | DNA Box 4 - E4, E5, E6, F4, F5, F6 | Confirmed | Yes |
| 701 | C>T | 2, 8, 12 | DNA Box 4 - G4, G5, G6, H4, H5, H6 | Confirmed | Yes |
| 803 | G>A | 1 , 7 , 9 | DNA Box 1 - E1, E2, E3, F1, F2, F3 | Confirmed | No |
| 1017 | G>A | 1, 7, 10 | DNA Box 2- E1, E2, E3, F1, F2, F3 | Confirmed | No |
| 1044 | G>A | 1, 5, 11 | DNA Box 3- A1, A2, A3, B1, B2, B3 | Confirmed | Yes |
| 1089 | G>A | 4, 7, 12 | DNA Box 4 - E10, E11, E12, F10, F11, F12 | Confirmed | Yes |
| 1288 | C>T | 4, 7, 10 | DNA Box 2- E10, E11, E12, F10, F11, F12 | Confirmed | Yes |
| 1399 | G>A | 2, 8, 11 | DNA Box 3 - G4, G5, G6, H4, H5, H6 | Confirmed | No |
| 1454 | G>A | 2, 6, 12 | DNA Box 4 - C4, C5, C6, D4, D5, D6 | Confirmed | Yes |
| 1477 | G>A | 3, 8, 11 | DNA Box 3 -A7, A8, A9, B7, B8, B9 | Confirmed | Yes |
| 1506 | G>A | 2, 6, 11 | DNA Box 3 - C4, C5, C6, D4, D5, D6 | Confirmed | Yes |
Figure 2Diagrammatic representation of the distribution of mutations identified by classical TILLING and by SCAMPRing.
The BnSAD gene was used as a test to compare the effectiveness of NGS sequencing (SCAMPRing) vs. classical TILLING. Purple arrows indicate silent changes in the gene that are predicted to have no effect on the protein gene product. Black arrows indicate predicted missense mutations that alter the amino acid sequence of the protein product. Red arrows indicate predicted nonsense mutations that result in premature truncation of the protein. Circles indicate mutations that were detected using SCAMPRing but not originally found with classical TILLING.